Showing results (31-40 of 6,841) with videos related to
Sort By:
Pageof 685
Bulletin of the World Health Organization|May 4, 2005
Advance price or purchase commitments to create markets for treatments for diseases of poverty: lessons from three policiesAdrian Towse, Hannah KettlerInternational Journal of Technology Assessment in Health Care|December 3, 2013
Approaches to identifying, measuring, and aggregating elements of valueAdrian Towse, Paul BarnsleyHealth Economics|June 26, 2019
Do cancer treatments have option value? Real-world evidence from metastatic melanomaMeng Li, Anirban Basu, Caroline S Bennette, et al.Rheumatology and Therapy|January 14, 2017
Estimating the Cost of Illness of Giant Cell Arteritis in the United StatesJoseph B Babigumira, Meng Li, Denise M Boudreau, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 10, 2024
Does Real Option Value Influence Oncologists' Treatment Recommendations? A Survey of US OncologistsMeng Li, Zizi Elsisi, William Wong, et al.The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|September 29, 2004
Genetic screening, health care and the insurance industry. Should genetic information be made available to insurers?Diego F Ossa, Adrian TowseInternational Journal of Health Care Finance and Economics|November 25, 2003
Differential pricing for pharmaceuticals: reconciling access, R&D and patentsPatricia M Danzon, Adrian TowseCurrent Medical Research and Opinion|March 22, 2012
Retrospective outcomes studies for orphan diseases: challenges and opportunitiesPeter Sun, Louis P GarrisonPharmacoeconomics|May 8, 2022
Modeling the Ex Ante Clinical Real Option Value in an Innovative Therapeutic Area: ALK-Positive Non-Small-Cell Lung CancerWoojung Lee, William B Wong, Stacey Kowal, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|March 23, 2022
Is the world ready for gene therapy?Louis P Garrison, Diane KleinermansPageof 685